RealPharma: Conversations with Pharma Pathfinders

Beyond the Job Title: Mastering the Pharma Job Market with Kristiaan Rawlings

This episode discusses the biopharmaceutical job market and the impact of the COVID-19 pandemic. It explores the state of the job market, including layoffs and hiring trends in the industry. The conversation also delves into the role of recruiters in the life sciences industry and provides insights into their day-to-day activities.Additionally, it offers advice for candidates on how to approach working with recruiters and highlights the importance of building long-term relationships. The episode concludes with a discussion on the impact of technology on job applications. In this conversation, Kristiaan discusses the current hot areas in the industry, including GLP-1s, dermatology, neurology, ophthalmology, and respiratory. He also talks about the trend of title deflation and how candidates should focus on the responsibilities and long-term opportunities rather than just the title. Kristiaan provides insights into compensation trends, including base salaries, bonuses, and long-term incentives.He also addresses the topic of work onsite vs. remote and how companies are expecting employees to be onsite two to three times a week. Finally, he shares advice on charting your path and being willing to do what others won't to achieve your goals.Chapters00:00 - Introduction to the Biopharmaceutical Job Market02:05 - State of the Job Market and Layoffs in the Biopharmaceutical Industry03:31 - The Impact of the Great Resignation on the Pharmaceutical Industry06:07 - The Influence of Disease Areas on Hiring Trends08:30 - The Commercial Space in the Biopharmaceutical Industry12:55 - A Day in the Life of a Life Sciences Recruiter19:33 - Different Approaches and Business Models of Recruiters24:51 - How Candidates Should Approach Working with Recruiters27:49 - Building Long-Term Relationships with Recruiters32:00 - Success Stories of Candidates Who Overcame Challenges37:13 - The Impact of Technology on Job Applications43:48 - Hot Areas in the Industry48:23 - Title Deflation57:26 - Compensation Trends01:02:33 - Work Onsite vs. Remote01:09:01 - Charting Your PathResourcesKristiaan Rawlings LinkedInEPM ScientificBiopharma Layoff Tracker 2023BioSpace: How to Prepare for Your Biopharma Job Search

Navigating the Ethical Maze: Dr. Arthur Caplan on Bioethics in Modern Medicine

Dr. Arthur Caplan, a distinguished bioethicist, discusses various topics related to bioethics. He highlights the importance of bioethics in areas such as organ transplantation, genetic testing, artificial intelligence, and personalized medicine.Dr. Caplan emphasizes the need for informed consent in research ethics and the importance of providing research participants with the results of studies. He also addresses the ethical considerations in organ transplantation, including the allocation of scarce resources and the role of living donors. Additionally, he discusses the ethical implications of expensive treatments and the allocation of limited resources in healthcare. The conversation explores the disparity in healthcare attention given to rare diseases compared to chronic conditions. It highlights the need for organized advocacy and lobbying for conditions that lack representation.The discussion also delves into the balance between investing in genetic therapies for rare diseases and preventive measures for chronic conditions. The ethical considerations of gene editing using CRISPR technology are examined, including the need for monitoring and surveillance of adverse effects. The potential for societal inequalities in access to gene editing is discussed, raising concerns about eugenics and the widening gap between those who can afford the technology and those who cannot.Chapters00:00 Introduction to Dr. Arthur Caplan01:35 The Importance of Bioethics in Various Areas09:25 Informed Consent in Research Ethics17:29 Balancing Scientific Progress and Ethical Considerations in Human Subject Research33:41 Ethical Considerations in Organ Transplantation47:22 Healthcare Resource Utilization and Pricing48:25 Disparity in Healthcare Attention51:18 Balancing Rare Diseases and Chronic Conditions53:36 Genetics vs. Environmental Intervention58:26 CRISPR and Bioethical Concerns01:05:13 Societal Inequalities in Access to Gene Editing01:06:03 Inspiration from Ben FranklinResourcesDr. Arthur CaplanSuccumbing to AI with a whimper, not a bangWorking Group on Compassionate Use and Preapproval Access (CUPA)Vaccine Working Group on Ethics and PolicyWorking Group on Pediatric Gene Therapy & Medical EthicsTransplant Ethics and Policy If you donate DNA, what should scientists give in return? A ‘pathbreaking’ new modelTreating the dead; how far ought medicine go to obtain transplantable organs?Consideration and Disclosure of Group Risks in Genomics and Other Data-Centric Research: Does the Common Rule Need Revision?Research involving the recently deceased: ethics questions that must be answeredRegaining Trust in Public Health and Biomedical Science following Covid: The Role of ScientistsProtect newborn screening programsWhy the Gene Was (Mis)Placed at the Center of American Health Policy

Trailer

Coming January 2024! RealPharma Podcast is your gateway to the world of biopharmaceuticals and healthcare. Your hosts are two industry veterans who engage in in-depth conversations with pharma pathfinders/leaders who are shaping the future of medicine. Hear the stories behind the news that challenge traditional viewpoints and offer fresh perspectives that will make you rethink what you know about the healthcare industry.